Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
EyePoint, Inc. - Common Stock
(NQ:
EYPT
)
13.85
+0.12 (+0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EyePoint, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Mizuho's Top Stock Picks For November Revealed
↗
November 05, 2023
As trading for November begins, Mizuho recommends a few stocks for investors to consider.
Via
Benzinga
Expert Ratings for EyePoint Pharmaceuticals
↗
November 02, 2023
Via
Benzinga
Why Is Vision Disorder-Focused EyePoint Pharmaceuticals Stock Trading Higher Today?
↗
November 01, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q3 revenues of $15.20 million, up from $10 million a year ago and beating
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 28, 2023
Via
Benzinga
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
↗
September 11, 2023
The company reported positive trial data for its lead therapy to treat two different eye conditions.
Via
The Motley Fool
Where EyePoint Pharmaceuticals Stands With Analysts
↗
July 28, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About EyePoint Pharmaceuticals
↗
June 28, 2023
Via
Benzinga
5 Analysts Have This to Say About EyePoint Pharmaceuticals
↗
June 06, 2023
Via
Benzinga
EyePoint Pharmaceuticals: Q1 Earnings Insights
↗
May 03, 2023
Via
Benzinga
Why's Going On With EyePoint Pharmaceuticals Stock Today?
↗
September 11, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced interim masked safety data for its lead product candidate EYP-1901 from its ongoing Phase 2 PAVIA trial of EYP-1901 as a potential nine-month...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 13, 2023
Via
Benzinga
Why Are EyePoint Pharmaceuticals Shares Trading Higher Today
↗
July 10, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating
Via
Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
↗
June 14, 2023
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
↗
June 14, 2023
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
↗
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
↗
May 18, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).
Via
Benzinga
Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today
↗
May 03, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q1 revenues of $7.68 million, down from $9.3 million a year ago but slightly
Via
Benzinga
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments
May 02, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END
Via
FinancialNewsMedia
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 24, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday
↗
April 24, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
↗
April 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...
Via
Benzinga
EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21
April 21, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
↗
April 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
↗
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
Eyepoint Pharmaceuticals Inc. (NASDAQ: EYPT) Leading the Way in Monday Trading Based on Percentage Gain
March 27, 2023
Via
Investor Brand Network
Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout
↗
March 16, 2023
Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
